350 related articles for article (PubMed ID: 23346859)
1. Proliferation and significance of clinically relevant β-lactamases.
Bush K
Ann N Y Acad Sci; 2013 Jan; 1277():84-90. PubMed ID: 23346859
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria.
Bush K; Fisher JF
Annu Rev Microbiol; 2011; 65():455-78. PubMed ID: 21740228
[TBL] [Abstract][Full Text] [Related]
3. Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae.
Bush K
Curr Opin Microbiol; 2010 Oct; 13(5):558-64. PubMed ID: 20920882
[TBL] [Abstract][Full Text] [Related]
4. [Clinically important beta-lactamases of gram-negative bacteria: extended-spectrum beta-lactamases (ESBL)].
Hrabák J
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):103-11. PubMed ID: 17900058
[TBL] [Abstract][Full Text] [Related]
5. What's new in antibiotic resistance? Focus on beta-lactamases.
Babic M; Hujer AM; Bonomo RA
Drug Resist Updat; 2006 Jun; 9(3):142-56. PubMed ID: 16899402
[TBL] [Abstract][Full Text] [Related]
6. The evolution of beta-lactamases.
Bush K
Ciba Found Symp; 1997; 207():152-63; discussion 163-6. PubMed ID: 9189640
[TBL] [Abstract][Full Text] [Related]
7. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.
Shah AA; Hasan F; Ahmed S; Hameed A
Res Microbiol; 2004; 155(6):409-21. PubMed ID: 15249058
[TBL] [Abstract][Full Text] [Related]
8. [Beta-lactamases in laboratory and their role in resistance Part I.: Evolution of bacterial resistance mediated by beta-lactamases].
Bedenić B
Lijec Vjesn; 2004; 126(11-12):314-24. PubMed ID: 16082890
[TBL] [Abstract][Full Text] [Related]
9. NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases.
Livermore DM; Mushtaq S; Warner M; Miossec C; Woodford N
J Antimicrob Chemother; 2008 Nov; 62(5):1053-6. PubMed ID: 18689875
[TBL] [Abstract][Full Text] [Related]
10. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
11. A set of multiplex PCRs for genotypic detection of extended-spectrum β-lactamases, carbapenemases, plasmid-mediated AmpC β-lactamases and OXA β-lactamases.
Voets GM; Fluit AC; Scharringa J; Cohen Stuart J; Leverstein-van Hall MA
Int J Antimicrob Agents; 2011 Apr; 37(4):356-9. PubMed ID: 21353487
[TBL] [Abstract][Full Text] [Related]
12. [Beta-lactamases and their role in resistance. PART 2: beta-lactamases in 21st century].
Bedenić B
Lijec Vjesn; 2005; 127(1-2):12-21. PubMed ID: 16145868
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a DNA microarray for the rapid detection of extended-spectrum β-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM).
Cuzon G; Naas T; Bogaerts P; Glupczynski Y; Nordmann P
J Antimicrob Chemother; 2012 Aug; 67(8):1865-9. PubMed ID: 22604450
[TBL] [Abstract][Full Text] [Related]
14. New definitions of extended-spectrum β-lactamase conferring worldwide emerging antibiotic resistance.
Lee JH; Bae IK; Lee SH
Med Res Rev; 2012 Jan; 32(1):216-32. PubMed ID: 20577973
[TBL] [Abstract][Full Text] [Related]
15. Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns.
Rapp RP; Urban C
Pharmacotherapy; 2012 May; 32(5):399-407. PubMed ID: 22488420
[TBL] [Abstract][Full Text] [Related]
16. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter.
Livermore DM; Woodford N
Trends Microbiol; 2006 Sep; 14(9):413-20. PubMed ID: 16876996
[TBL] [Abstract][Full Text] [Related]
17. Oligonucleotide microarrays with horseradish peroxidase-based detection for the identification of extended-spectrum β-lactamases.
Rubtsova MY; Ulyashova MM; Edelstein MV; Egorov AM
Biosens Bioelectron; 2010 Dec; 26(4):1252-60. PubMed ID: 20643540
[TBL] [Abstract][Full Text] [Related]
18. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens.
Pfeifer Y; Cullik A; Witte W
Int J Med Microbiol; 2010 Aug; 300(6):371-9. PubMed ID: 20537585
[TBL] [Abstract][Full Text] [Related]
19. Minor extended-spectrum beta-lactamases.
Naas T; Poirel L; Nordmann P
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():42-52. PubMed ID: 18154527
[TBL] [Abstract][Full Text] [Related]
20. Bench-to-bedside review: The role of beta-lactamases in antibiotic-resistant Gram-negative infections.
Bush K
Crit Care; 2010; 14(3):224. PubMed ID: 20594363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
